Jiangsu Aidea Pharmaceutical Group Company Description

Jiangsu Aidea Pharmaceutical Group Co., Ltd. develops, produces, and sells pharmaceutical products in China and internationally.

It offers anti-HIV drugs and human-derived proteins. The company also provides anti-virus products, such as ainuovirine tablets; urinary protein products, including crude product/intermediate of ulinastatin, urinary kallidinogenase, and urokinase; sennae folium granules; and baicillus cereus tablets.

It also exports its products. The company was formerly known as Jiangsu Aidea Pharmaceutical Co., Ltd. and changed its name to Jiangsu Aidea Pharmaceutical Group Co., Ltd. in July 2025.

Jiangsu Aidea Pharmaceutical Group Co., Ltd. was founded in 2009 and is headquartered in Yangzhou, China.

Jiangsu Aidea Pharmaceutical Group Co., Ltd.

Country	China
Founded	2009
Industry	Biotechnology
Sector	Healthcare
Employees	760
CEO	Jie Zhang

Contact Details

Address: No. 69, Xinganquan West Road Yangzhou, 225008 China
Phone	86 514 8753 0666
Website	aidea.com.cn

Stock Details

Ticker Symbol	688488
Exchange	Shanghai Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
ISIN Number	CNE1000041S6
SIC Code	2834

Key Executives

Name	Position
Jie Zhang	Chief Executive Officer, President and Director
Yan Liu	Financial Director, Board Secretary, Accounting Supervisor and Director
Guang Rong Wang	Vice President and Director
Gaohong Gu	Senior Vice President
Tie Sun	Head of Biopharmaceutical Research & Development
Hong Qin	Vice President
Qide Li	Director of Pharmaceutical Research Institute
Yu Yuan	Quality Center Director
Gufang Su	Deputy Director of Process Research & Development